Edesa Biotech, Inc. (NASDAQ:EDSA – Get Free Report) CEO Pardeep Nijhawan acquired 5,000 shares of the stock in a transaction dated Monday, March 25th. The stock was acquired at an average price of $4.00 per share, for a total transaction of $20,000.00. Following the purchase, the chief executive officer now directly owns 341,702 shares in […]
Edesa Biotech, Inc. (NASDAQ:EDSA – Get Free Report) CEO Pardeep Nijhawan purchased 5,000 shares of the company’s stock in a transaction dated Monday, March 25th. The shares were bought at an average price of $4.00 per share, for a total transaction of $20,000.00. Following the completion of the transaction, the chief executive officer now directly […]
Edesa Biotech, Inc. (NASDAQ:EDSA) CEO Pardeep Nijhawan Purchases 5,000 Shares themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
TORONTO, ON / ACCESSWIRE / February 9, 2024 / Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today reported financial results for the three months ended December 31, 2023 and provided an update on its bu.